BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang C, Duan C. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol 2020;13:19. [PMID: 32169087 DOI: 10.1186/s13045-020-00858-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu K, Han H, Luo Y, Ye H, Lin H, Ni L. The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation. Front Oncol 2021;11:663671. [PMID: 34221978 DOI: 10.3389/fonc.2021.663671] [Reference Citation Analysis]
2 Geng B, Zhu Y, Yuan Y, Bai J, Dou Z, Sui A, Luo W. Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis. Front Oncol 2021;11:714646. [PMID: 34476217 DOI: 10.3389/fonc.2021.714646] [Reference Citation Analysis]
3 Herrera-Vargas AK, García-Rodríguez E, Olea-Flores M, Mendoza-Catalán MA, Flores-Alfaro E, Navarro-Tito N. Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer. Cytokine Growth Factor Rev 2021:S1359-6101(21)00078-2. [PMID: 34736827 DOI: 10.1016/j.cytogfr.2021.10.006] [Reference Citation Analysis]
4 Wan F, Zhang H, Hu J, Chen L, Geng S, Kong L, Lu JJ. Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a. Front Oncol 2022;12:781979. [DOI: 10.3389/fonc.2022.781979] [Reference Citation Analysis]
5 Almahmoudi R, Salem A, Hadler-Olsen E, Svineng G, Salo T, Al-Samadi A. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma. Cancer Sci 2021;112:2223-32. [PMID: 33743555 DOI: 10.1111/cas.14894] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Massimini M, Romanucci M, De Maria R, Della Salda L. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Front Vet Sci 2021;8:722432. [PMID: 34631854 DOI: 10.3389/fvets.2021.722432] [Reference Citation Analysis]
7 Vieira de Castro J, Gonçalves CS, Hormigo A, Costa BM. Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting. Int J Mol Sci 2020;21:E5278. [PMID: 32722427 DOI: 10.3390/ijms21155278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Gao X, Hu B, Zhao Z, Niu T, Liu Y, Xu K, Tang B. Synthesis of Au Se bonded nanoprobe for specific detection of thrombin in lung cancer cells. Sensors and Actuators B: Chemical 2022;352:130999. [DOI: 10.1016/j.snb.2021.130999] [Reference Citation Analysis]
9 Pagano C, Navarra G, Pastorino O, Avilia G, Coppola L, Della Monica R, Chiariotti L, Florio T, Corsaro A, Torelli G, Caiazzo P, Gazzerro P, Bifulco M, Laezza C. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition. Int J Mol Sci 2021;22:10530. [PMID: 34638872 DOI: 10.3390/ijms221910530] [Reference Citation Analysis]
10 Zhang L, Kong L, He SY, Liu XZ, Liu Y, Zang J, Ju RJ, Li XT. The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice. Life Sci 2021;285:120013. [PMID: 34614418 DOI: 10.1016/j.lfs.2021.120013] [Reference Citation Analysis]
11 Uthamacumaran A, Suarez NG, Baniré Diallo A, Annabi B. Computational Methods for Structure-to-Function Analysis of Diet-Derived Catechins-Mediated Targeting of In Vitro Vasculogenic Mimicry. Cancer Inform 2021;20:11769351211009229. [PMID: 33953534 DOI: 10.1177/11769351211009229] [Reference Citation Analysis]
12 Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharmacol Res 2021;166:105507. [PMID: 33610718 DOI: 10.1016/j.phrs.2021.105507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Karinen S, Juurikka K, Hujanen R, Wahbi W, Hadler-Olsen E, Svineng G, Eklund KK, Salo T, Åström P, Salem A. Tumour cells express functional lymphatic endothelium-specific hyaluronan receptor in vitro and in vivo: Lymphatic mimicry promotes oral oncogenesis? Oncogenesis 2021;10:23. [PMID: 33674563 DOI: 10.1038/s41389-021-00312-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hussen BM, Abdullah ST, Rasul MF, Salihi A, Ghafouri-Fard S, Hidayat HJ, Taheri M. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets. Front Mol Biosci 2021;8:764025. [PMID: 34778378 DOI: 10.3389/fmolb.2021.764025] [Reference Citation Analysis]
15 Zhang J, Du Y, Gong L, Shao Y, Wen J, Sun L, He D, Guo J, Chen J, Shao C. EBV-Induced CXCL8 Upregulation Promotes Vasculogenic Mimicry in Gastric Carcinoma via NF-κB Signaling. Front Cell Infect Microbiol 2022;12:780416. [DOI: 10.3389/fcimb.2022.780416] [Reference Citation Analysis]
16 Zhang L, Wu H, Zhang Y, Xiao X, Chu F, Zhang L. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α). Bioengineered 2022;13:950-62. [PMID: 34969360 DOI: 10.1080/21655979.2021.2015530] [Reference Citation Analysis]
17 Fu R, Du W, Ding Z, Wang Y, Li Y, Zhu J, Zeng Y, Zheng Y, Liu Z, Huang JA. HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment. Cell Death Dis 2021;12:394. [PMID: 33850110 DOI: 10.1038/s41419-021-03682-z] [Reference Citation Analysis]
18 Xu H, Jiao D, Liu A, Wu K. Tumor organoids: applications in cancer modeling and potentials in precision medicine. J Hematol Oncol 2022;15:58. [PMID: 35551634 DOI: 10.1186/s13045-022-01278-4] [Reference Citation Analysis]
19 Zhang Y, Tan Y, Liu S, Yin H, Duan J, Fan L, Zhao X, Jiang B. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. Toxicol Mech Methods 2022;:1-9. [PMID: 35592903 DOI: 10.1080/15376516.2022.2075297] [Reference Citation Analysis]
20 de Faria Lainetti P, Brandi A, Leis Filho AF, Prado MCM, Kobayashi PE, Laufer-Amorim R, Fonseca-Alves CE. Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo. Front Vet Sci 2020;7:583874. [PMID: 33195606 DOI: 10.3389/fvets.2020.583874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Alvarez-Ochoa E, Froldi F, Cheng LY. Interorgan communication in development and cancer. Wiley Interdiscip Rev Dev Biol 2021;10:e394. [PMID: 32852143 DOI: 10.1002/wdev.394] [Reference Citation Analysis]
22 Charfi C, Demeule M, Currie JC, Larocque A, Zgheib A, Danalache BA, Ouanouki A, Béliveau R, Marsolais C, Annabi B. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells. Front Oncol 2021;11:760787. [PMID: 34751242 DOI: 10.3389/fonc.2021.760787] [Reference Citation Analysis]
23 Xu Y, Fu L, Pan D, Wei J, Xia H, Wang S, Sun G. Folic Acid Inhibited Vasculogenic Mimicry in Esophageal Cancer Cell Line Eca-109, the One Target Was EphA2. Nutr Cancer 2021;:1-8. [PMID: 34678082 DOI: 10.1080/01635581.2021.1988992] [Reference Citation Analysis]
24 Belotti D, Pinessi D, Taraboletti G. Alternative Vascularization Mechanisms in Tumor Resistance to Therapy. Cancers (Basel) 2021;13:1912. [PMID: 33921099 DOI: 10.3390/cancers13081912] [Reference Citation Analysis]
25 Rosińska S, Gavard J. Tumor Vessels Fuel the Fire in Glioblastoma. Int J Mol Sci 2021;22:6514. [PMID: 34204510 DOI: 10.3390/ijms22126514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Zhu T, Cheng Z, Peng X, Xing D, Zhang M. HIF-1α RNAi Combined with Asparagus Polysaccharide Exerts an Antiangiogenesis Effect on Hepatocellular Carcinoma In Vitro and In Vivo. Evid Based Complement Alternat Med 2021;2021:9987383. [PMID: 34335854 DOI: 10.1155/2021/9987383] [Reference Citation Analysis]
27 Luo Y, Wang J, Wang F, Liu X, Lu J, Yu X, Ma X, Peng X, Li X. Foxq1 promotes metastasis of nasopharyngeal carcinoma by inducing vasculogenic mimicry via the EGFR signaling pathway. Cell Death Dis 2021;12:411. [PMID: 33875643 DOI: 10.1038/s41419-021-03674-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zang M, Hou J, Huang Y, Wang J, Ding X, Zhang B, Wang Y, Xuan Y, Zhou Y. Crocetin suppresses angiogenesis and metastasis through inhibiting sonic hedgehog signaling pathway in gastric cancer. Biochem Biophys Res Commun 2021;576:86-92. [PMID: 34482028 DOI: 10.1016/j.bbrc.2021.08.092] [Reference Citation Analysis]
29 Song H, Liu Q, Liao Q. Circular RNA and tumor microenvironment. Cancer Cell Int 2020;20:211. [PMID: 32518520 DOI: 10.1186/s12935-020-01301-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
30 Banerjee R, Smith J, Eccles MR, Weeks RJ, Chatterjee A. Epigenetic basis and targeting of cancer metastasis. Trends in Cancer 2021. [DOI: 10.1016/j.trecan.2021.11.008] [Reference Citation Analysis]
31 Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 2021;13:3602. [PMID: 34298815 DOI: 10.3390/cancers13143602] [Reference Citation Analysis]
32 Hujanen R, Almahmoudi R, Salo T, Salem A. Comparative Analysis of Vascular Mimicry in Head and Neck Squamous Cell Carcinoma: In Vitro and In Vivo Approaches. Cancers (Basel) 2021;13:4747. [PMID: 34638234 DOI: 10.3390/cancers13194747] [Reference Citation Analysis]
33 Chemi F, Mohan S, Guevara T, Clipson A, Rothwell DG, Dive C. Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights. Front Oncol 2021;11:672195. [PMID: 34026650 DOI: 10.3389/fonc.2021.672195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Guiraldelli GG, Prado MCM, de F Lainetti P, Leis-filho AF, Kobayashi PE, Cury SS, Fonseca-alves CE, Laufer-amorim R. Pathways Involved in the Development of Vasculogenic Mimicry in Canine Mammary Carcinoma Cell Cultures. Journal of Comparative Pathology 2022;192:50-60. [DOI: 10.1016/j.jcpa.2022.01.001] [Reference Citation Analysis]
35 Song X, An Y, Chen D, Zhang W, Wu X, Li C, Wang S, Dong W, Wang B, Liu T, Zhong W, Sun T, Cao H. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Cancer Sci 2021. [PMID: 34811848 DOI: 10.1111/cas.15208] [Reference Citation Analysis]
36 Zhang X, Zhang JG, Mu W, Zhou HM, Liu GL, Li Q. The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib. Phytomedicine 2021;92:153740. [PMID: 34600176 DOI: 10.1016/j.phymed.2021.153740] [Reference Citation Analysis]
37 Kuehlbach C, Hensler S, Mueller MM. Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model. Bioengineering (Basel) 2021;8:186. [PMID: 34821752 DOI: 10.3390/bioengineering8110186] [Reference Citation Analysis]
38 Wu Y, Xu X, Liu M, Qin X, Wu Q, Ding H, Zhao Q. DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis. Biochem Pharmacol 2022;:115093. [PMID: 35580648 DOI: 10.1016/j.bcp.2022.115093] [Reference Citation Analysis]
39 Jin L, Chen C, Huang L, Bu L, Zhang L, Yang Q. Salvianolic acid A blocks vasculogenic mimicry formation in human non-small cell lung cancer via PI3K/Akt/mTOR signalling. Clin Exp Pharmacol Physiol 2021;48:508-14. [PMID: 33529404 DOI: 10.1111/1440-1681.13464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang N, Zhang S, Wu W, Lu W, Jiang M, Zheng N, Huang J, Wang L, Liu H, Zheng M, Wang J. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT. Mol Carcinog 2021;60:151-63. [PMID: 33428809 DOI: 10.1002/mc.23279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]